China Shineway Pharmaceutical Group Limited

Symbol: 2877.HK

HKSE

10.5

HKD

Market price today

  • 7.2080

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 7.22B

    MRK Cap

  • 0.06%

    DIV Yield

China Shineway Pharmaceutical Group Limited (2877-HK) Financial Statements

On the chart you can see the default numbers in dynamics for China Shineway Pharmaceutical Group Limited (2877.HK). Companys revenue shows the average of 1927.356 M which is 0.106 % gowth. The average gross profit for the whole period is 1345.502 M which is 0.136 %. The average gross profit ratio is 0.684 %. The net income growth for the company last year performance is 0.298 % which equals 0.132 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of China Shineway Pharmaceutical Group Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.143. In the realm of current assets, 2877.HK clocks in at 6782.399 in the reporting currency. A significant portion of these assets, precisely 5050.188, is held in cash and short-term investments. This segment shows a change of 0.200% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 1411.02, if any, in the reporting currency. This indicates a difference of -3.613% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 0.912 in the reporting currency. This figure signifies a year_over_year change of -0.501%. Shareholder value, as depicted by the total shareholder equity, is valued at 6382.526 in the reporting currency. The year over year change in this aspect is 0.082%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 975.062, with an inventory valuation of 657.66, and goodwill valued at 165.96, if any. The total intangible assets, if present, are valued at 47.35.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

19086.015050.242103948.3
3968.8
3618.7
3549.3
3218.4
2826.2
2688.1
2291.9
2212.4
2172.8
2349
2318.2
1585.6
1678.4
1583.9
1347.6
1146.6
295

balance-sheet.row.short-term-investments

8.023.74.35.3
22.8
7.2
16.9
0
0
0
0
0
0
0
0
0
0
1.9
0
0
0

balance-sheet.row.net-receivables

3912.03975.1825.2760.7
674.3
531.5
531.3
553.7
459.3
593.8
680
625.2
515.9
365.4
143.6
0
0
66.6
137.3
205.7
62.9

balance-sheet.row.inventory

2603.55657.7588443
430.8
405.5
280.2
294.4
340.9
285.7
244.5
204
282.8
191.9
136.3
76.3
78.4
38.2
35.5
18.2
46.3

balance-sheet.row.other-current-assets

343.47119.775.9367.1
129.2
97.3
199.5
184.5
214.1
382.1
660.8
19.9
27.8
35.1
86.7
351.8
287.7
21.3
17.8
0.4
35.5

balance-sheet.row.total-current-assets

25924.836782.45699.15519
5203.1
4652.9
4560.3
4251
3840.5
3949.7
3877.2
3061.4
2999.3
2941.4
2684.8
2013.8
2044.5
1710.1
1538.2
1370.8
439.7

balance-sheet.row.property-plant-equipment-net

4928.211216.912521394.8
1493.9
1403.7
1401.8
1466.5
1529
1574.7
1599.2
1546.3
1108.3
776.8
456.7
326.3
278.5
224.4
231.2
179.6
191.1

balance-sheet.row.goodwill

663.82166166102.5
159.3
159.3
159.3
159.3
159.3
99.7
91.7
91.7
91.7
91.7
58.5
58.5
58.5
58.5
58.5
0
0

balance-sheet.row.intangible-assets

209.1247.366.437
248.3
287.9
308
348.4
388.7
23.3
0.5
0.7
1.4
2.2
0.3
19.2
19.9
5.6
5.9
0
0

balance-sheet.row.goodwill-and-intangible-assets

872.94213.3232.4139.5
407.6
447.2
467.3
507.6
548
122.9
92.2
92.4
93.1
93.8
58.8
77.7
78.4
64.1
64.4
0
0

balance-sheet.row.long-term-investments

5724.714111463.91511.1
1874.7
1822.7
1847.4
1952.5
2054
1673.5
1666
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

76.4419.220.523.1
26.8
28.2
21.7
21.6
23.1
24.1
25.4
25.9
25.8
6.6
7.5
8.7
7.3
9.2
11.5
9
0.3

balance-sheet.row.other-non-current-assets

-4337.23-1430.2-1484.4-1534.2
-1901.5
-1850.9
-21.7
-21.6
-23.1
-24.1
-25.4
17
150.4
153.5
62.1
0
0
0
0
11
0

balance-sheet.row.total-non-current-assets

5801.151430.21484.41534.2
1901.5
1850.9
1869.1
1974.1
2077.1
1697.7
1691.4
1681.6
1377.7
1030.7
585.1
412.7
364.2
297.7
307.1
199.6
191.4

balance-sheet.row.other-assets

76.4419.220.5160.2
26.8
228
235.7
240.2
235.6
259.9
169.7
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

31802.428231.972047213.5
7131.3
6731.8
6665.1
6465.3
6153.1
5907.3
5738.3
4743
4377
3972.1
3269.9
2426.5
2408.7
2007.7
1845.2
1570.4
631.1

balance-sheet.row.account-payables

1171.44308.7228.6164.4
189.4
213.1
230.8
219.1
224.1
202.5
219.6
274.8
289.8
202.8
225.2
64.1
89.2
102.5
86
131.3
73.9

balance-sheet.row.short-term-debt

3256.57.6377.1
403.1
0
0
0
0
200
500
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

335.16107.865.158.4
39.5
45.4
16.9
28.2
17.5
32.5
29.5
38.2
40.9
52.9
19.3
11.5
35.8
13.6
2.9
1
46.2

balance-sheet.row.long-term-debt-total

12.720.97.315
1.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

652.31164171.6204.3
127.9
125.1
73.9
109.1
92.6
104.8
99.9
90.3
0
74.7
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

81.72---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

4878.851356.8869.81030.3
988.6
567.2
478.5
453.9
477.5
483.5
460.4
380.3
356.5
463.9
322.7
225.6
250.3
136
129
1
47.1

balance-sheet.row.total-non-current-liabilities

746.74183.7204.1224.6
176.4
185.7
134.9
165.5
155.5
128.4
128.7
91.3
75.7
75.8
225.2
64.1
89.2
102.5
86
1.8
50.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
-225.2
-64.1
-89.2
-102.5
-86
0
0

balance-sheet.row.capital-lease-obligations

37.727.414.922.8
6.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

6804.631849.31302.51419.3
1354.4
966
844.2
838.6
857.1
1014.4
1308.7
746.4
722
742.6
547.8
289.7
339.5
238.5
215
134.1
171.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

350.6587.787.787.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
87.7
0
0
0
0

balance-sheet.row.retained-earnings

24925.186367.658795777.8
5724.2
5410.6
4986.9
4623
4293.9
3908.2
3476.3
2472.4
0
0
0
0
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
0
0
0
-443.2
-367.6
-303.6
-251.7
-208.1
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-278.04-72.8-65.2-71.3
-35
267.5
746.4
916
914.4
896.7
865.1
1879.3
3934.3
3445.5
2886.1
2257.1
1981.6
1769.3
1630.2
1412.7
395.7

balance-sheet.row.total-stockholders-equity

24997.796382.55901.55794.2
5776.9
5765.8
5821
5626.7
5296
4892.5
4429.1
3996.1
3654.4
3229.6
2722.1
2136.7
2069.3
1769.3
1630.2
1412.7
395.7

balance-sheet.row.total-liabilities-and-stockholders-equity

31802.428231.972047213.5
7131.3
6731.8
6665.1
6465.3
6153.1
5907.3
5738.3
4743
4377
3972.1
3269.9
2426.5
2408.7
2007.7
1845.2
1570.4
631.1

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0.4
0.5
0.5
0.6
0
0
0
0
0
0
23.5
63.9

balance-sheet.row.total-equity

24997.796382.55901.55794.2
5776.9
5765.8
5821
5626.7
5296
4892.9
4429.6
3996.6
3655
3229.6
2722.1
2136.7
2069.3
1769.3
1630.2
1436.3
459.6

balance-sheet.row.total-liabilities-and-total-equity

31802.42---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

2857.783.74.35.3
22.8
7.2
16.9
0
0
0
0
17
0
0
0
0
0
1.9
0
0
0

balance-sheet.row.total-debt

337.727.414.9392.1
404.5
0
0
0
0
200
500
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-18720.04-5018.8-4190.8-3550.9
-3541.5
-3611.5
-3532.4
-3218.4
-2826.2
-2488.1
-1791.9
-2212.4
-2172.8
-2349
-2318.2
-1585.6
-1678.4
-1582
-1347.6
-1146.6
-295

Cash Flow Statement

The financial landscape of China Shineway Pharmaceutical Group Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.608. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 0 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -45420000.000 in the reporting currency. This is a shift of -1.115 from the previous year. In the same period, the company recorded 185.86, 96.69, and -7.68, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -241.73 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -0.63, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

cash-flows.row.net-income

1462.46722.8556.7295
503.1
505.9
451.6
589.2
657.9
704.8
683.6
799.7
949.5
991.8
884
476.2
575.9
333
337
260.8
151.4

cash-flows.row.depreciation-and-amortization

365.02185.9182.4208.4
205
197.5
194.6
191
162.4
144.3
98.1
82
65.7
53
45.3
36
32.1
29.7
25.8
22.3
22

cash-flows.row.deferred-income-tax

00207.1105.3
171.1
121.1
-43.9
43.8
-119.5
-76.8
185
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000.1
1.1
4.4
7.4
6.1
17.8
31.5
14
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-435.51-228.4-207.1-105.5
-172.1
-125.5
36.5
-49.9
101.7
45.2
-198.9
-6.8
-231.4
-280.2
413
-96.9
-169
85.5
109.2
-57.3
-15.8

cash-flows.row.account-receivables

-225.67-158.7-67-93.3
-146.8
-0.2
22.3
-96.4
141.8
86.2
-158.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-209.84-69.7-140.1-12.2
-25.3
-125.3
14.2
46.4
-40.1
-41
-40.5
78.8
-90.8
-49.7
-60
2
-40.2
-2.7
-17.3
28.1
-8.7

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
0
0
0
0
0
0
-85.6
-140.6
-230.6
473
-98.9
-128.8
88.3
126.5
-85.4
-7.1

cash-flows.row.other-non-cash-items

362.21429.5-35.9135.1
-340.1
-170.8
-199.5
-3
-195.1
-152.7
-76.9
-239.3
-298.7
-185.2
-285.1
-10.1
-37.1
-30.8
-14.3
5.1
11.8

cash-flows.row.net-cash-provided-by-operating-activities

1754.18000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-238.79-129.5-93.6-66
-88.4
-127.3
-91.8
-96.3
-106.6
-104.2
-261.9
-368.9
-396.6
-368.9
-221.2
-84.2
-92.6
-23.2
-73.1
-22.4
-25.5

cash-flows.row.acquisitions-net

00.99.4-137.1
-36.5
-54.7
0
-80.7
-301.1
-38
16.7
-16.7
59.6
-54.6
0
0
0
0
-80.8
0
0

cash-flows.row.purchases-of-investments

0-320.2-370-2494.9
-900
-415.8
0
45.9
-300
-37.1
-208.8
-268
-151.6
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0306.7379.12539.8
936.5
470.5
48
34.8
345.2
75
238.6
316.5
154.8
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

173.696.7470.2-147.3
157.9
240.3
128.3
62.5
233.2
295.2
-460.4
47
5.6
186.8
-47
48.7
39.1
34.2
17.9
0.8
0.2

cash-flows.row.net-cash-used-for-investing-activites

-65.19-45.4395-305.6
69.5
112.9
84.5
-79.7
-129.2
228.1
-675.7
-290.1
-328.2
-236.6
-268.2
-35.5
-53.5
10.9
-136
-21.6
-25.3

cash-flows.row.debt-repayment

-7.16-7.7-7.7-4.7
-4
-608.5
0
0
-200
-515
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

003.7-36.4
-244
-304.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

004.1-36.4
-244
-304.3
0
0
0
0
0
0
0
0
0
0
0
0
-10.2
0
0

cash-flows.row.dividends-paid

-770.51-241.7-453.1-173.6
-178.8
-187.7
-190.2
-190.2
-190.2
-190.2
-190.2
-306
-330.8
-314.3
-181.9
-330.8
-190.2
-181.9
-82.7
-32
-74.8

cash-flows.row.other-financing-activites

284.3-0.6-375.9-78.7
570.1
839.2
-74.4
-74.4
-83.5
100.2
425.6
0
0.6
0
0
0
0
0
-6.7
674.3
-113.2

cash-flows.row.net-cash-used-provided-by-financing-activities

-486.21-250-828.9-329.8
-100.7
-565.4
-264.6
-264.6
-473.7
-605
235.4
-306
-330.2
-314.3
-181.9
-330.8
-190.2
-181.9
-99.6
642.3
-188

cash-flows.row.effect-of-forex-changes-on-cash

9.916.3-6.5-6.2
2.3
-1
3.5
3
-3.7
0
0
0
-2.8
2.3
125.4
-131.8
-61.8
-12
-21.1
0
0

cash-flows.row.net-change-in-cash

1212.69820.5262.7-3
334.5
79.1
314
392.2
138.1
396.2
79.5
39.6
-176.2
30.8
732.5
-92.8
96.4
234.4
201
851.6
-44

cash-flows.row.cash-at-end-of-period

19057.765026.34205.73943
3946
3611.5
3532.4
3218.4
2826.2
2688.1
2291.9
2212.4
2172.8
2349
2318.2
1585.6
1678.4
1582
1347.6
1146.6
295

cash-flows.row.cash-at-beginning-of-period

17845.074205.739433946
3611.5
3532.4
3218.4
2826.2
2688.1
2291.9
2212.4
2172.8
2349
2318.2
1585.6
1678.4
1582
1347.6
1146.6
295
339

cash-flows.row.operating-cash-flow

1754.181109.7703.1638.6
368
532.6
490.6
733.5
744.7
773.2
519.9
635.7
485.1
579.4
1057.3
405.3
402
417.4
457.6
230.9
169.3

cash-flows.row.capital-expenditure

-238.79-129.5-93.6-66
-88.4
-127.3
-91.8
-96.3
-106.6
-104.2
-261.9
-368.9
-396.6
-368.9
-221.2
-84.2
-92.6
-23.2
-73.1
-22.4
-25.5

cash-flows.row.free-cash-flow

1515.39980.2609.5572.5
279.6
405.2
398.8
637.2
638.1
669
258
266.8
88.5
210.6
836.1
321.1
309.4
394.2
384.6
208.6
143.9

Income Statement Row

China Shineway Pharmaceutical Group Limited's revenue saw a change of 0.226% compared with the previous period. The gross profit of 2877.HK is reported to be 2938.31. The company's operating expenses are 2119.76, showing a change of 18.216% from the last year. The expenses for depreciation and amortization are 185.86, which is a 0.023% change from the last accounting period. Operating expenses are reported to be 2119.76, which shows a 18.216% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.335% year-over-year growth. The operating income is 713.58, which shows a 0.335% change when compared to the previous year. The change in the net income is 0.298%. The net income for the last year was 722.77.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

income-statement-row.row.total-revenue

8018.773950.63223.62655.7
2706
2570.2
1919.6
1993.4
2054.8
2229.2
2187.1
2132.2
1984.5
2038.4
1633.2
1275.2
1012.9
841.5
831.4
703.6
604

income-statement-row.row.cost-of-revenue

2013.191012.3813.2667.9
724.4
694.1
652.5
706.9
693.9
751.2
712.7
740.3
682.5
603.4
455.1
360.9
274.8
249.2
274.8
252
315

income-statement-row.row.gross-profit

6005.582938.32410.31987.8
1981.6
1876
1267.1
1286.5
1360.9
1478
1474.4
1391.9
1302.1
1435
1178.1
914.3
738
592.3
556.6
451.6
289

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

253.34---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

561.72---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

3641.25---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

010582.986.2
86.1
38.8
4.7
4.7
8.5
5.7
1.6
0.3
-189.4
2.3
46.1
32.7
207.2
46.3
18.2
0.9
0.8

income-statement-row.row.operating-expenses

4285.582119.81793.11708.9
1455.6
1340.4
780.8
691.8
661.1
727.1
700.9
668
352.6
491.2
340.2
470.8
369.3
251.6
232.4
171.6
104.8

income-statement-row.row.cost-and-expenses

6298.773132.12606.32376.7
2180
2034.5
1433.3
1398.7
1355
1478.3
1413.6
1408.3
1035
1094.5
795.4
831.7
644.2
500.7
507.1
423.6
419.8

income-statement-row.row.interest-income

20898.5102.9116.1
116.8
133.4
101.6
100.6
97.3
112.8
86.1
31.6
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

00.61.316.6
2.7
0
0
0
0.1
16.9
3.3
-124.3
0
-48
-46.1
-32.7
-207.2
-46.3
-18.2
8.5
40.2

income-statement-row.row.selling-and-marketing-expenses

3641.25---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

400.28203.4185.7-27.4
166.3
174.8
179.8
130.7
183
163.2
169.7
124.3
0
48
46.1
32.7
207.2
46.3
18.2
0.9
0.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

010582.986.2
86.1
38.8
4.7
4.7
8.5
5.7
1.6
0.3
-189.4
2.3
46.1
32.7
207.2
46.3
18.2
0.9
0.8

income-statement-row.row.total-operating-expenses

400.28203.4185.7-27.4
166.3
174.8
179.8
130.7
183
163.2
169.7
124.3
0
48
46.1
32.7
207.2
46.3
18.2
0.9
0.8

income-statement-row.row.interest-expense

00.61.316.6
2.7
0
0
0
0.1
16.9
3.3
-124.3
0
-48
-46.1
-32.7
-207.2
-46.3
-18.2
8.5
40.2

income-statement-row.row.depreciation-and-amortization

342.17174.7170.7199.4
196.2
197.5
194.6
191
162.4
144.3
98.1
82
65.7
53
45.3
36
32.1
29.7
25.8
22.3
22

income-statement-row.row.ebitda-caps

1869.89---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

1527.72713.6534.4422.4
476.5
494.3
408.1
564.6
614.2
700.5
690
675.4
949.5
943.8
837.9
443.5
368.7
340.7
324.2
279.9
184.3

income-statement-row.row.income-before-tax

1927.99917720.1395
642.8
669.1
587.8
695.3
797.2
863.7
859.6
799.7
949.5
991.8
884
476.2
575.9
387
342.5
280.8
185.1

income-statement-row.row.income-tax-expense

465.54194.3163.4100
139.6
163.3
136.3
106.1
139.4
159
176
152.1
193.9
170.1
116.7
78
85.3
54.1
5.4
10.7
-7.3

income-statement-row.row.net-income

1462.46722.8556.7295
503.1
505.9
451.6
589.2
657.9
704.8
683.6
647.7
755.6
821.8
767.3
398.2
490.6
333
337
260.8
151.4

Frequently Asked Question

What is China Shineway Pharmaceutical Group Limited (2877.HK) total assets?

China Shineway Pharmaceutical Group Limited (2877.HK) total assets is 8231861000.000.

What is enterprise annual revenue?

The annual revenue is 4534122000.000.

What is firm profit margin?

Firm profit margin is 0.754.

What is company free cash flow?

The free cash flow is 1.148.

What is enterprise net profit margin?

The net profit margin is 0.195.

What is firm total revenue?

The total revenue is 0.211.

What is China Shineway Pharmaceutical Group Limited (2877.HK) net profit (net income)?

The net profit (net income) is 722773000.000.

What is firm total debt?

The total debt is 7442000.000.

What is operating expences number?

The operating expences are 2119757999.000.

What is company cash figure?

Enretprise cash is 5364576000.000.